GLP-1 Pep-LNP
Cat. No.: TDLD-0126-LD92
GLP-1 Pep-LNP
GLP-1 Pep-LNP is an advanced peptide-functionalized lipid nanoparticle (LNP) engineered with GLP-1 Peptide, which targets GLP-1 receptors on pancreatic beta cells, aiding diabetes treatment and obesity management. Please note that this product is intended for research purposes only.
Inquiry
SPECIFIC INQUIRY
Clear All
For Research Use Only. Not for Diagnostic or Treatment Applications.
| Payload Type | mRNA |
| Payload | Empty; EGFP mRNA; Firefly Luciferase mRNA; mCherry mRNA; GFP mRNA; OVA mRNA; EPO mRNA; Renilla Luciferase mRNA; Gaussia Luciferase mRNA; Beta-galactosidase mRNA; Cre mRNA; mOrange mRNA; tdTomato mRNA; EYFP mRNA; Others |
| Capping | Cap 1 |
| Modification | Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other |
| Module Type | Peptide |
| Targeting Module | GLP-1 Peptide |
| Target | Insulin β cells |
| Lipid Formulation | DLin-MC3-DMA; LP-01; ALC-0315; SM102; Other |
| Dye | Unlabeled; DiR; DiD; DiO; DiI; Other |
| Application | Control; Targeted Delivery; Gene Therapy |
| Format | Liquid |
| Concentration | 0.1 mg/mL; 0.2 mg/mL; Other (Please Specify) |
| Size | 65-120 nm |
| PDI | < 0.2 |
| Zeta | ± 20.0 mV |
| Encapsulate Efficiency | >90% |
| Shipping | Dry Ice |
| Storage | Store at -80°C |
Related Products
R6H4 Pep-LNP (TDLD-0825-LD85)
OVA mRNA-LNP (TDLD-0825-LD13)
Cy3-labeled Fluc mRNA-LNP (TDLD-0825-LD25)
HGGVRLY Pep-LNP (TDLD-0126-LD102)
Pep-1 Pep-LNP (TDLD-0126-LD125)
c(RGDfC) Pep-LNP (TDLD-0126-LD72)
CD7 CAR mRNA-LNP (TDLD-0825-LD30)
KIT CAR mRNA-LNP (TDLD-0825-LD36)
Online Inquiry
